nimodipine has been researched along with Bilateral Deafness in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nimodipine is a calcium-channel antagonist that has provided protection from cisplatin-induced neurotoxicity in a rat model system." | 2.69 | Clinical trials of nimodipine as a potential neuroprotector in ovarian cancer patients treated with cisplatin. ( Cassidy, J; Habeshaw, T; Kaye, SB; Parkin, D; Paul, J; Reed, NS; Soukop, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wildemann, B | 1 |
| Schülin, C | 1 |
| Storch-Hagenlocher, B | 1 |
| Hacke, W | 1 |
| Dithmar, S | 1 |
| Kirchhof, K | 1 |
| Jansen, O | 1 |
| Breitbart, A | 1 |
| Cassidy, J | 1 |
| Paul, J | 1 |
| Soukop, M | 1 |
| Habeshaw, T | 1 |
| Reed, NS | 1 |
| Parkin, D | 1 |
| Kaye, SB | 1 |
1 trial available for nimodipine and Bilateral Deafness
| Article | Year |
|---|---|
Clinical trials of nimodipine as a potential neuroprotector in ovarian cancer patients treated with cisplatin.
Topics: Adult; Aged; Antineoplastic Agents; Calcium Channel Blockers; Cisplatin; Double-Blind Method; Drug A | 1998 |
1 other study available for nimodipine and Bilateral Deafness
| Article | Year |
|---|---|
Susac's syndrome: improvement with combined antiplatelet and calcium antagonist therapy.
Topics: Adult; Aspirin; Calcium Channel Blockers; Cerebrovascular Disorders; Drug Combinations; Female; Hear | 1996 |